Jiuqiang Biosciences: Obtained two medical device registration certificates.

Jiuqiang Bio announced that the company has recently received the "Medical Device Registration Certificate" issued by the Beijing Municipal Food and Drug Administration, including the thrombin III test kit and the bone calcium test kit, both of which are registered as Class II, valid until July 5, 2031. This enriches the company's in vitro diagnostic product line, which is conducive to enhancing competitiveness and expanding the market, and has a positive impact on operations. However, sales will depend on market promotion, and the impact on performance cannot be predicted at this time.